BARTOLINI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 17.459
NA - Nord America 11.480
AS - Asia 4.215
SA - Sud America 625
AF - Africa 130
OC - Oceania 107
Continente sconosciuto - Info sul continente non disponibili 3
Totale 34.019
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.396
PL - Polonia 11.355
RU - Federazione Russa 2.260
SG - Singapore 1.153
CN - Cina 1.030
SE - Svezia 739
IT - Italia 678
IE - Irlanda 667
HK - Hong Kong 663
BR - Brasile 542
UA - Ucraina 502
KR - Corea 481
DE - Germania 426
VN - Vietnam 327
GB - Regno Unito 277
FI - Finlandia 243
FR - Francia 140
IN - India 137
AU - Australia 104
ID - Indonesia 104
TR - Turchia 88
NL - Olanda 49
JO - Giordania 46
CA - Canada 44
JP - Giappone 44
CI - Costa d'Avorio 40
AR - Argentina 34
SC - Seychelles 34
MX - Messico 28
BD - Bangladesh 23
CH - Svizzera 22
BE - Belgio 20
ES - Italia 17
IQ - Iraq 17
PK - Pakistan 17
ZA - Sudafrica 15
MA - Marocco 11
AT - Austria 10
PE - Perù 10
PY - Paraguay 10
SA - Arabia Saudita 10
AZ - Azerbaigian 9
CO - Colombia 9
LT - Lituania 9
TH - Thailandia 9
EC - Ecuador 8
EG - Egitto 8
IL - Israele 8
UZ - Uzbekistan 8
BG - Bulgaria 7
CZ - Repubblica Ceca 7
NP - Nepal 6
RO - Romania 6
KE - Kenya 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
HR - Croazia 4
LV - Lettonia 4
TW - Taiwan 4
VE - Venezuela 4
AM - Armenia 3
AO - Angola 3
BJ - Benin 3
BO - Bolivia 3
DZ - Algeria 3
IR - Iran 3
LA - Repubblica Popolare Democratica del Laos 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
PH - Filippine 3
UY - Uruguay 3
BY - Bielorussia 2
IS - Islanda 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
MD - Moldavia 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KZ - Kazakistan 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
Totale 34.013
Salva come PNG Salva come JPEG
Città #
Warsaw 11.350
Santa Clara 1.928
Ashburn 1.183
Fairfield 1.091
Jacksonville 745
Singapore 722
Dublin 666
Chandler 607
Hong Kong 533
Woodbridge 505
Seattle 475
Cambridge 456
Wilmington 407
Seoul 390
Houston 380
Beijing 271
Hefei 261
Dong Ket 223
Altamura 170
Ann Arbor 165
Princeton 165
Los Angeles 160
Buffalo 158
Boardman 148
Lawrence 137
Boston 118
The Dalles 106
Melbourne 103
Mumbai 102
Dallas 101
Paris 96
Jakarta 93
San Diego 85
Phoenix 78
Moscow 73
Seongnam 73
Medford 71
Munich 70
Milan 69
Izmir 61
Shanghai 59
Falls Church 55
Kent 43
New York 43
Helsinki 42
Abidjan 40
Florence 40
Washington 40
Council Bluffs 37
Tokyo 37
São Paulo 34
London 28
Turku 28
Frankfurt Am Main 26
Hanoi 26
Norwalk 26
Auburn Hills 25
Hillsboro 24
West Jordan 24
Guangzhou 23
Frankfurt am Main 22
Ho Chi Minh City 21
Verona 21
Bern 20
Brussels 20
Redondo Beach 20
Andover 18
Dearborn 18
Groningen 17
Chicago 15
Amsterdam 14
Montreal 14
Tianjin 14
Toronto 14
Yubileyny 14
Brooklyn 12
North Bergen 12
Rio de Janeiro 12
Zhengzhou 12
Belo Horizonte 11
Philadelphia 11
Rome 11
Johannesburg 10
San Francisco 10
Stockholm 10
Baku 9
Columbus 9
Las Vegas 9
North Charleston 9
Tappahannock 9
Atlanta 8
Bengaluru 8
Manchester 8
Mcallen 8
Ottawa 8
Poplar 8
Saint Louis 8
San Jose 8
Bremen 7
Campinas 7
Totale 25.791
Salva come PNG Salva come JPEG
Nome #
M1 receptor activation is a requirement for arecoline analgesia. 569
DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer 525
Antinociceptive property of the nicotinic agonist AG4 in rodents 498
AMITRIPTYLINE AND CLOMIPRAMINE ACTIVATE GI-PROTEIN SIGNALING PATHWAY IN THE INDUCTION OF ANALGESIA 366
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 366
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity 364
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 359
AG-4:A NICOTINIC AGONIST ENDOWED WITH ANTIAMNESIC PROPERTIES 353
HYPOFUNCTIONALITY OF GI PROTEINS AS AETIOPHATOGENETIC MECHANISM FOR MIGRAINE AND CLUSTER HEADACHE 353
The novel nootropic compound DM232 (UNIFIRAM) ameliorates memory impairment in mice and rats 352
A Prolonged Protein Kinase C-Mediated, Opioid-Related Antinociceptive Effect of St John's Wort in Mice 341
3-ALFA-TROPANYL 2-(4-Cl-PHENOXY)BUTIRATE (SM21): A REVIEW OF THE PHARMACOLOGICAL PROFILE OF A NOVEL ENHANCER OF CHOLINERGIC TRANSMISSION. 334
A REDUCED FUNCTIONALITY OF GI PROTEINS AS A POSSIBLE CAUSE FOR FIBROMYALGIA 332
S(-)ET126: a potent and selective M1 antagonist in vitro and in vivo 332
Acetyl-l-Carnitine in the Management of Pain During Methadone Withdrawal Syndrome. 332
5-HT1A AGONISTS INDUCE CENTRAL CHOLINERGIC ANTINOCICEPTION 331
A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice. 314
Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception. 308
Antisense knockdowns of M1 receptors induces transient anterograde amnesia in mice 307
Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. 306
LOCAL ANAESTHETIC ACTIVITY OF (+) AND (-) MENTHOL 305
PIRACETAM AND ANIRACETAM ANTAGONISM OF CENTRALLY ACTIVE DRUG-INDUCED ANTINOCICEPTION 300
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 300
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8 296
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling. 295
Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: An antisense study. 294
NO DEVELOPMENT OF TOLERANCE TO ANALGESIA BY REPEATED ADMINISTRATION OF H1 ANTAGONISTS 293
ACETYL-L-CARNITINE INDUCES MUSCARINIC ANTINOCICEPTION IN MICE AND RATS 293
Local anaesthetic activity of beta-caryophyllene. 293
Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice. 292
EFFECT OF POTASSIUM CHANNEL MODULATORS IN MOUSE FORCED SWIMMING TEST 291
Central muscarinic antinociception induced by ET-142 and SS-20 in rodents 288
ANTINOCICEPTIVE PROFILE OF THE NATURAL CHOLINESTERASE INHIBITOR HUPERZINE A 287
Prochlorperazine induces central antinociception mediated by the muscarinic system. 286
Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. 285
IMPROVEMENT OF COGNITIVE FUNCTIONS BY THE ACETYLCHOLINE RELEASER SM21 282
Effect of K+ channel modulation on mouse feeding behaviour 282
Role of intracellular calcium in acute thermal pain perception 282
ROLE OF 5-HT1A RECEPTORS IN A MOUSE PASSIVE AVOIDANCE PARADIGM 280
Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. 280
Alpha-2 agonits induce amnesia through activation of the Gi-protein signalling pathway. 277
Loss of muscarinic antinociception by antisense inhibition of M1 receptors. 277
Pro-cognitive activity induced in the rat by low doses of R-(+)-hyoscyamine. 276
PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL ACH RELEASER A-TROPANYL 2-(4-BROMOPHENYL)PROPIONATE (PG-9). 275
KV1.1 CHANNEL ANTISENSE ATTENUATES LEARNING AND MODULATION OF DENTATE POLYSIALYLATED NCAM 273
Influence of potassium channel modulators on cognitive processes in mice 272
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 271
Role of Gi proteins in the antidepressant-like effect of amitriptyline and clomipramine. 271
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 2. 2-Phenoxy-, 2-(phenylthio)- and 2-(phenylamino)alkanoic Acid Esters 269
An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown. 269
Memory facilitation with atropine: a paradoxical effect 269
ANTIAMNESIC ACTIVITY OF THE NICOTINIC AGONIST DBO-83 IN MICE 269
ANTINOCICEPTIVE EFFECT OF R-(+)-HYOSCYAMMINE ON THE CONJUNCTIVAL REFLEX TEST IN RABBITS 269
EFFECT OF PERTUSSIS TOXIN ON BACLOFEN-AND DIPHENHYDRAMINE- INDUCED AMNESIA 266
THE CENTRAL CHOLINERGIC SYSTEM HAS A ROLE IN THE ANTINOCICEPTION INDUCED IN RODENTS AND GUINEA-PIGS BY THE ANTIMIGRAINE DRUG SUMATRIPTAN 266
Endogenous morphine modulates acute thermonociception in mice. 266
ROLE OF 5-HT4 RECEPTORS IN THE MOUSE PASSIVE AVOIDANCE TEST 265
THE ROLE OF POTASSIUM CHANNELS IN ANTIHISTAMINE ANALGESIA 265
Diphenhydramine-induced amnesia is mediated by Gi-protein activation. 264
Different involvement of type 1, 2, and 3 ryanodine receptors in memory processes. 264
In vitro characterization of a novel, potent and selective M3 antagonist 261
Ryanodine receptors are involved in muscarinic antinociception in mice. 261
Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like potassium channe 260
Antinociceptive and antiamnesic properties of the presynaptic amplifier PG-9 260
ANTIAMNESIC EFFECT OF THE TWO NOVEL K-OPIOID AGONISTS, VA-100 AND VA-101, IN THE MOUSE PASSIVE AVOIDANCE TEST 260
Baclofen antinociception is prevented by ICV injection of pertussis toxin and by an aODN to the mKv1.1 potassium channel.. 260
ANTIHISTAMINE ANTINOCICEPTION IS MEDIATED BY GI-PROTEIN ACTIVATION 259
CENTRAL CHOLINERGIC CHALLENGING OF MIGRAINE BY TESTING SECOND-GENERATION ANTICHOLINESTERASE DRUG 258
Involvement of potassium channels in amitriptyline and clomipramine analgesia. 257
Caffeine induces central cholinergic analgesia. 256
Neuropathy-induced apoptosis: Protective effect of physostigmine 255
Inactivation of Gi proteins induces an antidepressant-like effect in the mouse forced-swimming test. 254
H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway. 253
ANTINOCICEPTION INDUCED BY SM32 DEPENDS ON CENTRAL CHOLINERGIC MECHANISM 251
Analgesic and antineuropathic drugs acting through central cholinergic mechanisms 248
Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and rat 244
Effect of pertussis toxin on morphine, diphenhydramine, baclofen, clomipramine and physostigmine antinociception. 241
Involvement of central cholinergic system in antinociception induced by sumatriptan in mouse. 239
PHARMACOLOGICAL IDENTIFICATION OF SM-21, THE NOVEL SIGMA2 ANTAGONIST 235
Memory facilitation and stimulation of endogenous nerve growth factor synthesis by the ACh releaser PG9 235
Antagonism by piracetam of baclofen antinociception 232
Are the contractions of rabbit peripheral lung, guinea-pig gall-bladder and guinea-pig uterus mediated by identical receptor subtype? 226
Role of potassium channels in the antinociception induced by agonists of alpha2-adrenoceptors 224
Binding Profiles of a Series of 2-Arylpropionic Acid Esters on Cloned Human Muscarinic Receptors Subtypes (m1-m5) and Their Relationship to Nootropic Activity 216
ANTINOCICEPTION INDUCED BY AMITRIPTYLINE AND IMIPRAMINE IS MEDIATED BY A2A-ADRENOCEPTORS 216
Differential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against Gi-protein a subunits. 205
INVESTIGATION INTO THE ROLE OF HISTAMINE RECEPTORS IN RODENT ANTINOCICEPTION 182
AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram). 179
1,4-Diazabicyclo[4.3.0]nonan-9-ones and 1,4-diamidopiperazines as new classes of highly potent nootropic drugs 178
Antidepressant-like effect of artemin in mice: a mechanism for acetyl-l-carnitine activity on depression 177
S-(-)-ET126: a potent and selective M1 antagonist 177
ANALGESIC, ANTIMUSCARINIC ACTIVITY AND ENANTIOSELECTIVITY OF THE FOUR ISOMERS OF 3-QUINUCLIDINYL TROPATE AS COMPARED WITH THE ENANTIOMERS OF HYOSCYAMINE 175
Gi/o proteins: expression for direct activation enquiry 171
Synthesis and Enantioselectivity of the Enantiomers of PG9 and SM21, New Potent Analgesic and Cognition-Enhancing Drugs 170
Chiral synthesis and pharmacological evaluation of the enantiomers of SM32, a new analgesic and cognition-enhancing agent. 167
ANTINOCICEPTION INDUCED BY SYSTEMIC ADMINISTRATION OF LOCAL ANAESTHETICS DEPENDS ON A CENTRAL CHOLINERGIC MECHANISM 166
1,4-Diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs 165
INVOLVEMENT OF CENTRAL CHOLINERGIC NEUROTRANSMISSION IN METOCLOPRAMIDE ANALGESIA 164
PRESYNAPTIC AUTO- AND HETERO-RECEPTORS IN THE CHOLINERGIC REGULATION OF PAIN 163
CGP 35348, A NEW GABAB ANTAGONIST, PREVENTS ANTINOCICEPTION AND MUSCLE-RELAXANT EFFECT INDUCED BY BACLOFEN 161
Totale 27.300
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.911
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.911
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.315 0 0 0 0 0 474 206 337 277 550 82 389
2021/20221.296 29 155 106 36 65 74 55 75 77 86 247 291
2022/20232.779 261 464 135 206 241 505 383 158 257 13 102 54
2023/20241.453 57 132 219 72 81 228 48 449 29 49 45 44
2024/20256.621 241 684 416 892 1.815 824 134 368 299 273 430 245
2025/20264.020 834 1.098 673 422 852 141 0 0 0 0 0 0
Totale 34.164